Immediate Impact
2 from Science/Nature 53 standout
Citing Papers
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
2023 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Works of R.M. Milstein being referenced
Five-component model of schizophrenia: Assessing the factorial invariance of the positive and negative syndrome scale
1994
Concurrent validity of the cognitive component of schizophrenia: Relationship of PANSS scores to neuropsychological assessments
1994
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| R.M. Milstein | 741 | 136 | 326 | 241 | 11 | 891 | |
| Scott Yale | 759 | 151 | 391 | 245 | 19 | 1.1k | |
| Tonko Hoffman | 499 | 98 | 212 | 277 | 8 | 770 | |
| Michael Foster Green | 665 | 157 | 328 | 197 | 11 | 1.0k | |
| Adanna Onyejiaka | 580 | 147 | 266 | 141 | 15 | 796 | |
| Margaret Knutelska | 654 | 122 | 560 | 212 | 23 | 1.1k | |
| Joost á Campo | 594 | 173 | 413 | 232 | 23 | 914 | |
| G. Reine | 681 | 190 | 283 | 193 | 22 | 832 | |
| Denise Gretchen‐Doorly | 832 | 104 | 247 | 223 | 17 | 992 | |
| Mary H. Thornquist | 595 | 178 | 386 | 206 | 14 | 1.1k | |
| Virginia N. Iannone | 674 | 84 | 217 | 135 | 11 | 908 |
All Works
Loading papers...